Beaudart, C., Malréchauffé, Y., van Heden, S., Sanchez-Rodriguez, D., Scheen, A., Bruyère, O., Mobasheri, A., Duque, G., Rizzoli, R., Reginster, J.-Y., & Thiyagarajan, J. A. (2026). GLP-1 receptor agonists and musculoskeletal outcomes: A systematic literature review and meta-analysis. Drugs, 86(10), 1661–1691. https://doi.org/10.1007/s40265-026-02365-3
Chu, J., Zhang, H., Wu, Y., Huang, Y., Zhu, T., Zhou, Z., & Wang, H. (2025). Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: A systematic review and meta-analysis. eClinicalMedicine, 88, Article 103464. https://doi.org/10.1016/j.eclinm.2025.103464
de Paulo, R. S., Bonifácio, D. B., de Carvalho, M. H. L., & Bressan, J. (2026). Dietary strategies and nutritional management in patients receiving GLP-1 and dual GIP/GLP-1 receptor agonists as adjuncts to lifestyle interventions: A systematic review of randomised clinical trials. Diabetes, Obesity and Metabolism, 28(7), 5492–5507. https://doi.org/10.1111/dom.70779
Soliman, A. T., Alyafei, F., Khalil, A., Kardousha, A. T., Ahmed, S., Alaaraj, N., & Hamed, N. (2026). GLP-1 receptor agonists in pediatric obesity and diabetes: A systematic review of efficacy, metabolic effects, and safety. Diabetes Research and Clinical Practice, 238, Article 113400. https://doi.org/10.1016/j.diabres.2026.113400
Woźniak, M., Tarcz, Z., Pyczek, G., Bogacka, J., Diniejko, A., Kuryłowicz, A., Mamcarz, A., & Śliż, D. (2026). The impact of glucagon-like peptide-1 (GLP-1) receptor agonists on body composition in individuals with overweight and obesity: A systematic review and meta-analysis. Journal of Clinical Medicine, 15(17), Article 6818. https://doi.org/10.3390/jcm15176818